Market Insights Health Medical Technology Medical Devices

Diagnostic Imaging Devices - Panama

Panama

The Diagnostic Imaging Devices market market in Panama is set to achieve a projected revenue of US$59.55m in 2024.
This indicates a steady growth rate, with revenue expected to increase at a compound annual growth rate (CAGR 2024-2029) of 6.84%.
As a result, the market volume is anticipated to reach US$82.90m by 2029.
When compared globally, it is worth noting that the United States will generate the majority of revenue in this market.
In 2024, the United States is projected to generate a substantial revenue of US$11,930.00m.
Panama's diagnostic imaging device market is experiencing a surge in demand due to the country's growing healthcare infrastructure.

Key regions: Germany, Japan, Netherlands, Spain, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Diagnostic Imaging Devices market in Panama is experiencing steady growth due to increasing customer preferences for advanced medical technologies, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Panama are shifting towards diagnostic imaging devices that offer high-quality imaging, improved accuracy, and faster results. Patients and healthcare professionals are increasingly demanding advanced imaging technologies such as MRI, CT scans, and ultrasound for accurate diagnosis and treatment planning. This preference for advanced imaging devices is driven by the need for early detection and prevention of diseases, as well as the desire for non-invasive procedures that minimize patient discomfort. Trends in the market indicate a growing demand for portable and handheld diagnostic imaging devices in Panama. These devices offer convenience and flexibility, allowing healthcare professionals to perform imaging procedures at the patient's bedside or in remote locations. The portability of these devices also enables faster diagnosis and treatment decisions, leading to improved patient outcomes. Additionally, there is a rising trend towards the integration of diagnostic imaging devices with other healthcare technologies, such as electronic health records and telemedicine, to facilitate seamless data sharing and remote consultations. Local special circumstances in Panama, such as the increasing prevalence of chronic diseases and the growing elderly population, are driving the demand for diagnostic imaging devices. Chronic diseases such as cardiovascular diseases, cancer, and respiratory diseases require regular monitoring and diagnosis, which can be facilitated by advanced imaging technologies. The aging population in Panama also contributes to the increased demand for diagnostic imaging devices, as elderly individuals are more prone to age-related diseases and require frequent medical imaging for diagnosis and treatment. Underlying macroeconomic factors in Panama, such as rising healthcare expenditure and government initiatives to improve healthcare infrastructure, are supporting the growth of the diagnostic imaging devices market. The government of Panama has been investing in the development of healthcare facilities and expanding access to advanced medical technologies, including diagnostic imaging devices. This investment is driven by the goal of providing quality healthcare services to the population and improving healthcare outcomes. In conclusion, the Diagnostic Imaging Devices market in Panama is witnessing growth due to customer preferences for advanced imaging technologies, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for high-quality imaging, portable devices, and integration with other healthcare technologies is driving the market forward. Furthermore, the increasing prevalence of chronic diseases, the growing elderly population, and government initiatives to improve healthcare infrastructure are contributing to the growth of the market in Panama.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.